RetaMaps

Reflections Medical

Reflections Medical · 2845 Niles Avenue · St.. Joseph, MI 49085

4.8· 18 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

Reflections Medical is a medical spa and salon in St. Joseph, Michigan, with a second office in Portage, per its website. The site says it uses aesthetic technology and certified medical staff to build individualized treatment plans, and it offers an online virtual consultation; the listing shows aesthetics as its service. It holds a 4.8-star Google rating across 18 reviews dating back to 2021, with one in the past year, and reviewers mention the staff, the providers' knowledge and caring treatment.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.8
Google rating · 18 reviews
1
reviews in the past year (avg ★ 5.0)

Counts computed by RetaMaps from public Google reviews; most recent review 2026-05-12. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.8 across 18 Google reviews. Of the 15 reviews we analyzed, 14 (93%) are positive (4–5★) and 1 (7%) are negative (1–2★).

What patients like

  • Friendly, helpful staff4 reviews
  • Knowledgeable, professional providers3 reviews
  • Feeling listened to3 reviews
  • Easy scheduling and communication2 reviews

Common complaints

Very few complaints — only 1 negative review, with no recurring theme.

5★
14
4★
0
3★
0
2★
0
1★
1

Most recent Google reviews

Anita H.★★★★★2025-05-05

I absolutely love Reflections Medical. I recently had the opportunity to receive a massage from Melanie. Let me tell you, it was an absolute privilege! She was professional, made me feel very comfortable, and the massage sent me into another dimension. She was also able to recognize areas which needed less pressure and more pressure and adjusted accordingly. This is no cookie cutter masseuse, she’s the real deal. Can’t wait to see her again!

Krishna P.★★★★★2024-01-17

Allisha was wonderful and always willing to work with me and my crazy schedule. I would highly recommend her.

Rachael M.★★★★★2024-01-10

This is definitely a 100% recommend! I've received nothing but top notch service and everything has exceeded expectations.

Soti M.★★★★★2023-03-13

Great experience every time!

St.joeGrl★★★★★2023-01-24

LOVE, LOVE this spa! First, Alisha does an amazing job running the office and with body procedures. Michael does the best facial I have ever had! Not just in the St. Joe area but in several metropolitan areas as well. Dr. Mosier is absolutely wonderful with cosmetic procedures - explains options and creates a natural look. So happy I found them and I can't recommend them enough!

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in St.. Joseph

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs